Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00522873 · ClinicalTrials.gov registry record · Phase 3
Endometrial Safety Study
A Phase 3 study of Postmenopause, sponsored by Bayer.
- Completed
- Registry status
- Phase 3
- Development phase
- 662
- Enrollment target
- 20
- Study locations
NCT00522873 is a Phase 3 study of Postmenopause that has completed, run by Bayer. The registered enrollment target is 662 participants, above the 126-participant average among 5 other Postmenopause trials with a reported enrollment target (425% higher). The trial reports 20 study locations across 15 states.
The verdict
NCT00522873, a Phase 3 study of Postmenopause, has completed, sponsored by Bayer.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 662 participants
- Enrollment target
- 20
- Study locations
Study Summary
The study is designed to investigate the safety of the investigational product for the lining of the uterus (endometrium).
Conditions Studied
Interventions
- DRUG 0.25mg DRSP / 0.5mg E2 (BAY86-4891)
- DRUG 0.5mg NETA / 1.0mg E2 (Activella)
Study Locations (20)
California
- - San Diego
- - San Diego
Colorado
- - Denver
- - Greenwood Village
Florida
- - Boynton Beach
- - Clearwater
Louisiana
- - Amite
- - Marrero
Buenos Aires
- - Lanús Oeste
- - San Isidro
Arizona
- - Chandler
Idaho
- - Boise
Nevada
- - Las Vegas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 662 participants |
| Start Date | 2007-08 |
| Est. Completion | 2009-08 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00522873
The ClinicalTrials.gov registry entry for NCT00522873 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 662 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 126-participant average among 5 other Postmenopause trials with a reported enrollment target (425% higher). The listed sponsor is Bayer, which has 591 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Postmenopause appearing as the primary indexed condition, and to 2 interventions - of which 0.25mg DRSP / 0.5mg E2 (BAY86-4891) is the first listed.
NCT00522873 reports 20 study locations spanning 15 distinct geographic areas - top geographies include California, Colorado, Florida.
Frequently Asked Questions
What is clinical trial NCT00522873 about?
NCT00522873 is a clinical study titled "Endometrial Safety Study". The study is designed to investigate the safety of the investigational product for the lining of the uterus (endometrium).
What is the current status of trial NCT00522873?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 662 participants. The study started on 2007-08. Estimated completion is 2009-08.
What conditions does trial NCT00522873 study?
This clinical trial studies the following conditions: Postmenopause.
What interventions are being tested in trial NCT00522873?
The interventions under investigation include: 0.25mg DRSP / 0.5mg E2 (BAY86-4891) (DRUG), 0.5mg NETA / 1.0mg E2 (Activella) (DRUG).
Who is sponsoring clinical trial NCT00522873?
This trial is sponsored by Bayer, which has 591 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00522873 being conducted?
This trial has 20 study locations across Arizona, California, Colorado, Florida, Idaho. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Postmenopause
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
GLYLO Supplement Pilot Trial on Glycation and Aging in Postmenopausal Women
RECRUITING · NA
-
Phytoestrogens and Memory Decline in Menopause
COMPLETED · Phase 2
-
Effects of Hormone Therapy on the Immune Systems of Postmenopausal Women With Chronic Infections
COMPLETED · Phase 2
-
Buccal Estrogen in Toothpaste Study: Systemic Absorption of Estradiol When Administered Mixed With Toothpaste in Postmenopausal or Surgically Menopausal Women
COMPLETED · NA
-
Effects of Black Cohosh on Menopausal Hot Flashes
COMPLETED · Phase 2
-
MyMenoPlan: Online Resource for Improving Women's Menopause Knowledge and Informed Decision-making
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.